SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc.
PVCT 0.0697-0.4%Nov 24 3:55 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LT2011 who wrote (11562)10/10/2012 5:31:39 PM
From: Khris Smith   of 13111
 
Shorting at this point could be very dangerous. I was looking at selling my common with the assumption that the preferred deal will go through under decent terms, and buying in to it. However, to assume the "IPO" will occur, and feel safe enough to sell one's shares, it might be tough to swallow if the shares run in the 'in between' time. Especially true if you have owned your common as long as most of "us". (I know, that sounds emotional, but there is also the tax implications of a long term hold).
I view the shorting of the common to be equal to my selling, and trying to replenish the shares through the preferred. Could work, but ?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News